The National Cancer Institute (NCI) is offering the Revision Applications for Mechanisms of Drug Resistance Grant to support the enhancement of existing research on drug resistance in cancer. This grant, associated with the Beau Biden Cancer MoonshotSM Initiative, aims to uncover mechanisms of resistance, design effective therapies, and target resistant tumors or their microenvironment. Applicants are encouraged to add new aims and directions to their current NCI Specialized Center–Cooperative Agreements. Closing date for submissions is June 23, 2021.
Opportunity ID: 320361
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-19-051 |
| Funding Opportunity Title: | Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.396 — Cancer Biology Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 06, 2019 |
| Last Updated Date: | Sep 06, 2019 |
| Original Closing Date for Applications: | Jun 23, 2021 |
| Current Closing Date for Applications: | Jun 23, 2021 |
| Archive Date: | Jul 29, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $250,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Special district governments Native American tribal organizations (other than Federally recognized tribal governments) City or township governments For profit organizations other than small businesses Private institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public housing authorities/Indian housing authorities County governments Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to support the addition of new aims and directions to currently funded NCI Specialized Center–Cooperative Agreements that will inform on underlying mechanisms of resistance, preclinical design and foster development of single or combination therapies to effectively target resistant/refractory tumors and/or their microenvironment at the clinical level. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-051.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00254662 | Sep 24, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00258930 | Sep 24, 2019 | Jun 23, 2021 | View |
Package 1
Mandatory forms
320361 RR_SF424_2_0-2.0.pdf
320361 PHS398_CoverPageSupplement_4_0-4.0.pdf
320361 RR_OtherProjectInfo_1_4-1.4.pdf
320361 PerformanceSite_2_0-2.0.pdf
320361 RR_KeyPersonExpanded_2_0-2.0.pdf
320361 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
320361 PHS_Additional_IndirectCosts-1.0.pdf
320361 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
320361 RR_SF424_2_0-2.0.pdf
320361 PHS398_CoverPageSupplement_5_0-5.0.pdf
320361 RR_OtherProjectInfo_1_4-1.4.pdf
320361 PerformanceSite_2_0-2.0.pdf
320361 RR_KeyPersonExpanded_2_0-2.0.pdf
320361 PHS398_ResearchPlan_4_0-4.0.pdf
320361 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
320361 PHS_Additional_IndirectCosts-1.0.pdf
320361 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
